Skip to content
OpenCapital
Get started

IQVIA IQV Research & Development Solutions — Goodwill

Other segment segments

Commercial Solutions
$12.92B—

Similar metrics at other companies

Fulgent Genetics, Inc. logo
FLGTTherapeutic Development — Goodwill
$22.35M+1.1%
ABM Industries logo
ABMTechnical Solutions — Goodwill
$461.4M+2.6%
Restoration Hardware logo
RHRH — Goodwill
$144.24M+2.3%
Newell Brands logo
NWLLearning and Development — Goodwill
$2.35B+1.4%
Hillman Solutions Corp. logo
HLMNRobotics and Digital Solutions — Goodwill
$210.36M-4.8%
Amentum Holdings logo
AMTMDS — Goodwill
$2.26B-6.5%

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$32.25B+17.5%
Enterprise value$46.37B+12.8%
P/E23.3×+1.1×
P/S1.9×+0.2×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's research & development solutions — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's research & development solutions — goodwill?
IQVIA (IQV) reported research & development solutions — goodwill of $3.62B in Q1 2026.
How has IQVIA's research & development solutions — goodwill changed year-over-year?
IQVIA's research & development solutions — goodwill increased by 38.5% year-over-year, from $2.62B to $3.62B.
What is the long-term trend for IQVIA's research & development solutions — goodwill?
Over 4 years (2021 to 2025), IQVIA's research & development solutions — goodwill has grown at a 14.8% compound annual growth rate (CAGR), from $6.91B to $11.99B.
What does research & development solutions — goodwill mean?
Reflects the intangible asset value recorded when the cost of an acquisition in the research and development segment exceeds the fair value of the identifiable net assets acquired. It represents the premium paid for expected synergies, market presence, and human capital within the clinical research business.